Depletion of kisspeptin/GPR54 signaling or downstream ERK5 signaling not only rescued the chronic stress‐induced tumor growth but also strengthened T cell‐mediated immune therapy by restricting T cell exhaustion. Here, KISS1 is linked to neoplasm.